AI Article Synopsis

  • * A study conducted in Chennai found that 71% of virally suppressed PLHIV showed significant neurocognitive impairment, despite long-term adherence to antiretroviral therapy and undetectable viral loads.
  • * The research revealed changes in proteins and metabolites linked to neuroinflammation and cognitive decline, emphasizing the need for targeted intervention strategies for improving long-term management of HIV-infected individuals.

Article Abstract

People living with HIV (PLHIV) are known to be at a higher risk of developing an array of aging-related diseases despite well-adhered combined antiretroviral therapy (cART). The present study aimed to investigate the impact of chronic HIV infection on neurocognitive function in virally suppressed PLHIV. We enrolled HIV-positive individuals randomly from an ART Center in Chennai, South India. A similar number of HIV-uninfected individuals matched for age and gender with the HIV-infected individuals served as controls. All individuals provided a detailed clinical history and underwent neuropsychological assessment using the International HIV Dementia Scale (IHDS). Plasma proteome analysis was performed using the Proximity extension assay (PEA) with the Olink® neuroexploratory panel, and untargeted metabolomics was performed using Ultra-High-Performance Liquid Chromatography/Mass Spectrometry/Mass Spectrometry. Despite a median duration of 9 years on first-line cART and suppressed viremia, a significant proportion of PLHIV registered significant levels of asymptomatic neurocognitive impairment, with 71% of these individuals scoring ≤ 10 in the IHDS test. We also observed significant alterations in a number of proteins and metabolites that are known to be associated with neuroinflammation, neurodegeneration, cognitive impairment, and gastrointestinal cancers, in the PLHIV group. Thus the study provides clinical as well as laboratory evidence to substantiate the presence of asymptomatic neurocognitive impairment in a large proportion of PLHIV, despite adequate cART and undetectable viremia, thereby supporting the view that HIV infection potentiates the risk for accelerated and accentuated neurological aging. This observation highlights the need to devise and implement appropriate intervention strategies for better long term management of HIV-infected persons.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11011-024-01458-wDOI Listing

Publication Analysis

Top Keywords

antiretroviral therapy
8
hiv infection
8
proportion plhiv
8
asymptomatic neurocognitive
8
neurocognitive impairment
8
individuals
6
plhiv
5
accelerated cognitive
4
cognitive aging
4
aging chronically
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!